Gilead Sciences, Inc.
Short
Updated

GILD triple top failed

117
GILD has been on a monster run, up one day, up the next and failed to pierce through the triple top. Bio pharma stocks are always difficult both short and long, every time I trade one it's always the last time. LOL $71 gap to fill
Note
Added again yesterday, another 200 puts. 400 total lol

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.